| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol 55, Issue 2 B106-B112, Copyright © 2000 by The Gerontological Society of America
JOURNAL ARTICLE |
PL Thornton, RL Ingram and WE Sonntag
Department of Physiology and Pharmacology, Wake Forest University, Winston-Salem, North Carolina 27157-1083, USA.
The age-related decline in growth hormone is one of the most robust endocrine markers of biological aging and has been hypothesized to contribute to the physiological deficits observed in aged animals. However, there have been few studies of the impact of this hormonal decline on brain aging. In this study, the effect of long-term subcutaneous administration of [D-Ala2]-growth hormone-releasing hormone (GHRH) on one measure of brain function, memory, was investigated. Animals were injected daily with 2.3 microg of [D-Ala2]- GHRH or saline from 9 to 30 months of age, and the spatial learning and reference memory of animals were assessed by using the Morris water maze and compared with those of 6-month-old animals. Results indicated that spatial memory decreased with age and that chronic [D-Ala2]-GHRH prevented this age-related decrement (24% improvement in the annulus-40 time and 23% improvement in the number of platform crossings compared with saline treated, age-matched controls; p < .05 each). No changes were noted in sensorimotor performance. [D-Ala2]-GHRH attenuated the age-related decline in plasma concentrations of insulinlike growth factor-1 (IGF-1) (p <.05). These data suggest that growth hormone and IGF-1 have important effects on brain function, that the decline in growth hormone and IGF-1 with age contributes to impairments in reference memory, and that these changes can be reversed by the chronic administration of GHRH.
This article has been cited by other articles:
 |
|
 |
|
  W. E. Sonntag, C. Bennett, R. Ingram, A. Donahue, J. Ingraham, H. Chen, T. Moore, J. K. Brunso-Bechtold, and D. Riddle Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E604 - E610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Mahmoud and L. M. Grover Growth Hormone Enhances Excitatory Synaptic Transmission in Area CA1 of Rat Hippocampus J Neurophysiol, May 1, 2006; 95(5): 2962 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Ramsey, M. M. Adams, O. J. Ariwodola, W. E. Sonntag, and J. L. Weiner Functional Characterization of Des-IGF-1 Action at Excitatory Synapses in the CA1 Region of Rat Hippocampus J Neurophysiol, July 1, 2005; 94(1): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Le Greves, P. Steensland, P. Le Greves, and F. Nyberg Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-D-aspartate receptor subunits gene transcripts in male rats PNAS, May 14, 2002; 99(10): 7119 - 7123. [Abstract] [Full Text] [PDF]
|
|
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
